Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy
Autor: | Joseph Moisseiev, Ivan Budnik, Irina S. Barequet, Yael Wasserzug, Ayelet Priel, Boris Shenkman, Ophira Salomon, Dan Sachs |
---|---|
Rok vydání: | 2011 |
Předmět: |
Male
Eye Hemorrhage medicine.medical_specialty Ticlopidine genetic structures medicine.drug_class medicine.medical_treatment Blood Loss Surgical Risk Assessment Postoperative Complications Lens Implantation Intraocular Thromboembolism medicine Humans Prospective Studies Intraoperative Complications Capsulorhexis Aged Aged 80 and over Prothrombin time Aspirin Phacoemulsification medicine.diagnostic_test business.industry Anticoagulant Warfarin Anticoagulants Middle Aged Cataract surgery Clopidogrel eye diseases Sensory Systems Surgery Ophthalmology Anesthesia Prothrombin Time Drug Therapy Combination Female business Platelet Aggregation Inhibitors medicine.drug |
Zdroj: | Journal of Cataract and Refractive Surgery. 37:1434-1438 |
ISSN: | 0886-3350 |
DOI: | 10.1016/j.jcrs.2011.02.035 |
Popis: | Purpose To assess the safety of phacoemulsification cataract extraction in patients on combined anticoagulant and antiplatelet treatment. Setting Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel. Design Prospective interventional case series. Methods Consecutive patients with simple cataract on combined anticoagulant (warfarin) and antiplatelet (aspirin or clopidogrel) treatment who were unable to discontinue the treatment because of a high risk for thromboembolic events were included. Patients had cataract extraction under topical anesthesia with a clear corneal incision (CCI), phacoemulsification, and implantation of a foldable posterior chamber intraocular lens. Prothrombin time–international normalized ratio and platelet functions were evaluated immediately before surgery. Patients were also examined 1 day and 7 days postoperatively. Intraoperative and postoperative ocular bleeding and other related complications were assessed. Results Forty patients (51 eyes) with a mean age of 72 years (range 51 to 90 years) had phacoemulsification. Hemorrhagic complications were not observed at surgery or during the 1-week follow-up. Surgical complications included 1 rupture of the capsulorhexis and 1 implantation of a capsular tension ring due to partial zonulysis. No patient had a thromboembolic event. Conclusions In patients with uncomplicated cataract at high risk for thromboembolic events, phacoemulsification cataract surgery using a CCI under topical needle-free anesthesia was safely performed without discontinuing systemic anticoagulant and antiplatelet treatment. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned. |
Databáze: | OpenAIRE |
Externí odkaz: |